Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
Phase 2
Completed
- Conditions
- Coronavirus Disease 2019 (COVID-19)
- Interventions
- Drug: PlaceboDrug: Prothione™ (6g)
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Prothione, LLC
- Target Recruit Count
- 231
- Registration Number
- NCT04742725
- Locations
- 🇷🇼
Rinda Ubuzima, Kigali, Rwanda
News
No news found